Stock screenerAll disclosures →
EDGAR →
VCEL
Conviction 100HealthcareScan · Fri, Jun 26, 2026VCEL$46.12+7.51%
ResistanceSupportVol 14Insider sell2
2
2
Vol MA14 783.61K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price46.12
Change+7.51%
Gap-0.29%
Rel volume4.01×
Avg volume739.36K
Avg $ vol29.04M
SMA 2038.05
SMA 5036.05
SMA 20035.66
Price vs 50+27.94%
Price vs 200+29.33%
MA stackbullish
50/200 crossgolden · 3d
Supertrendup · 39.19
RSI (14)83
MACD hist0.73
MACD cross—
Stoch %K / %D96 / 94
ADX (14)39
+DI / −DI40 / 5
RSI divergence—
MACD divergenceBullish
ATR %+3.87%
ADR %4.45%
52w high46.12
52w low29.34
From 52w high+0.00%
Above 52w low+57.19%
New 52w highYes
SqueezeOff
Bollinger width33.92%
%B1.12
Donchian pos96.98%
Donchian high46.56
Donchian low32.01
AVWAP (52w high)45.15
vs AVWAP high+2.14%
AVWAP (52w low)35.89
vs AVWAP low+28.49%
OBV trendUp
Chaikin MF (20)0.16
Today vs 20d4.01×
Avg vol (14d)783.61K
Avg vol (20d)739.36K
Avg $ vol (20d)29.04M
Market cap—
RS 3m (vs SPY)+24.65%
RS 6m (vs SPY)+7.57%
RS line new highYes
Trend template8/8
Technical rank90.0
1 week+15.01%
1 month+34.58%
3 months+49.64%
6 months+23.38%
1 year+10.12%
YTD+29.51%
P/E132.45
P/B6.14
P/S7.92
P/FCF88.40
EPS0.3200
Div yield—
ROE4.64%
ROA3.40%
Debt/Eq0.04
Current5.18
EV/EBITDA92.60
Gross margin74.42%
Net margin5.98%
Rev growth16.45%
EPS growth59.41%
Price target61.00
Target upside42.39%
Analyst ratingBuy
Institutional116.38%
Ent. value2.09B
Revenue68.42M
Net income-6.3M
Gross profit49.27M
Free cash flow24.75M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out51.07M
Employees398
ListedTue, Feb 4, 1997
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank90.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance39.95
Support31.96
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VCEL
No recent disclosed trades by Congress in VCEL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VCEL · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Halpin Michael Chief Operating Officer · Common Stock · 2026-06-18 | Sell | 10K | $402K | 2026-06-18 | 2026-06-22 |
Halpin Michael Chief Operating Officer · Stock Option (Right to Buy) · 2026-06-18 | Exercise | 10K | — | 2026-06-18 | 2026-06-22 |
Flynn Sean C. Chief Legal Officer · Stock Option (Right to Buy) · 2026-06-18 | Exercise | 15K | — | 2026-06-18 | 2026-06-22 |
Flynn Sean C. Chief Legal Officer · Common Stock · 2026-06-18 | Exercise | 15K | $244K | 2026-06-18 | 2026-06-22 |
Flynn Sean C. Chief Legal Officer · Common Stock · 2026-06-18 | Sell | 15K | $603K | 2026-06-18 | 2026-06-22 |
Halpin Michael Chief Operating Officer · Common Stock · 2026-06-18 | Exercise | 10K | $167K | 2026-06-18 | 2026-06-22 |
Hopper Jonathan Mark Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-02 | Exercise | 4.38K | $0 | 2026-06-02 | 2026-06-04 |
Hopper Jonathan Mark Chief Medical Officer · Common Stock · 2026-06-02 | Exercise | 4.38K | $73K | 2026-06-02 | 2026-06-04 |
Hopper Jonathan Mark Chief Medical Officer · Common Stock · 2026-06-02 | Sell | 4.38K | $153K | 2026-06-02 | 2026-06-04 |
MCLAUGHLIN KEVIN F Director · Common Stock · 2026-05-13 | Sell | 3.5K | $115K | 2026-05-13 | 2026-05-15 |
SEC filings
EDGAR filings in VCEL · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.